UNIVERSITY CLINICAL HEALTH has sponsored the creation of one or more 401k plans.
Submission information for form 5500 for 401k plan UNIVERSITY CLINICAL HEALTH 403B PLAN
Measure | Date | Value |
---|
2022 : UNIVERSITY CLINICAL HEALTH 403B PLAN 2022 401k financial data |
---|
Total unrealized appreciation/depreciation of assets | 2022-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-12-31 | $0 |
Total income from all sources (including contributions) | 2022-12-31 | $258,569 |
Total loss/gain on sale of assets | 2022-12-31 | $0 |
Total of all expenses incurred | 2022-12-31 | $860,705 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2022-12-31 | $839,225 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2022-12-31 | $2,202,101 |
Value of total assets at end of year | 2022-12-31 | $10,165,774 |
Value of total assets at beginning of year | 2022-12-31 | $10,767,910 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2022-12-31 | $21,480 |
Total interest from all sources | 2022-12-31 | $26,353 |
Total dividends received (eg from common stock, registered investment company shares) | 2022-12-31 | $163,429 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2022-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2022-12-31 | $163,429 |
Was this plan covered by a fidelity bond | 2022-12-31 | Yes |
Value of fidelity bond cover | 2022-12-31 | $500,000 |
If this is an individual account plan, was there a blackout period | 2022-12-31 | No |
Were there any nonexempt tranactions with any party-in-interest | 2022-12-31 | No |
Contributions received from participants | 2022-12-31 | $2,098,131 |
Participant contributions at end of year | 2022-12-31 | $197,789 |
Participant contributions at beginning of year | 2022-12-31 | $126,382 |
Participant contributions at end of year | 2022-12-31 | $30,043 |
Participant contributions at beginning of year | 2022-12-31 | $0 |
Assets. Other investments not covered elsewhere at end of year | 2022-12-31 | $22,654 |
Assets. Other investments not covered elsewhere at beginning of year | 2022-12-31 | $20,953 |
Income. Received or receivable in cash from other sources (including rollovers) | 2022-12-31 | $103,970 |
Value of other receiveables (less allowance for doubtful accounts) at end of year | 2022-12-31 | $570 |
Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2022-12-31 | $27 |
Other income not declared elsewhere | 2022-12-31 | $-4,828 |
Administrative expenses (other) incurred | 2022-12-31 | $21,480 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-12-31 | No |
Value of net income/loss | 2022-12-31 | $-602,136 |
Value of net assets at end of year (total assets less liabilities) | 2022-12-31 | $10,165,774 |
Value of net assets at beginning of year (total assets less liabilities) | 2022-12-31 | $10,767,910 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2022-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2022-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2022-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2022-12-31 | $8,907,303 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2022-12-31 | $9,885,229 |
Interest on participant loans | 2022-12-31 | $5,768 |
Interest earned on other investments | 2022-12-31 | $20,585 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2022-12-31 | $1 |
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2022-12-31 | $1 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2022-12-31 | $1 |
Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2022-12-31 | $1,007,414 |
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2022-12-31 | $735,318 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2022-12-31 | $-2,128,486 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2022-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2022-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2022-12-31 | No |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2022-12-31 | $839,225 |
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2022-12-31 | No |
Did the plan have assets held for investment | 2022-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2022-12-31 | No |
Opinion of an independent qualified public accountant for this plan | 2022-12-31 | Unqualified |
Accountancy firm name | 2022-12-31 | FORVIS, LLP |
Accountancy firm EIN | 2022-12-31 | 440160260 |
2021 : UNIVERSITY CLINICAL HEALTH 403B PLAN 2021 401k financial data |
---|
Total income from all sources (including contributions) | 2021-12-31 | $3,630,165 |
Total of all expenses incurred | 2021-12-31 | $600,995 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2021-12-31 | $579,371 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2021-12-31 | $2,374,450 |
Value of total assets at end of year | 2021-12-31 | $10,767,910 |
Value of total assets at beginning of year | 2021-12-31 | $7,738,740 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2021-12-31 | $21,624 |
Total interest from all sources | 2021-12-31 | $22,412 |
Total dividends received (eg from common stock, registered investment company shares) | 2021-12-31 | $164,523 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2021-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2021-12-31 | $164,523 |
Was this plan covered by a fidelity bond | 2021-12-31 | Yes |
Value of fidelity bond cover | 2021-12-31 | $500,000 |
If this is an individual account plan, was there a blackout period | 2021-12-31 | No |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2021-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2021-12-31 | No |
Contributions received from participants | 2021-12-31 | $1,922,681 |
Participant contributions at end of year | 2021-12-31 | $126,382 |
Participant contributions at beginning of year | 2021-12-31 | $165,178 |
Participant contributions at end of year | 2021-12-31 | $0 |
Participant contributions at beginning of year | 2021-12-31 | $29,462 |
Assets. Other investments not covered elsewhere at end of year | 2021-12-31 | $20,953 |
Assets. Other investments not covered elsewhere at beginning of year | 2021-12-31 | $20,180 |
Income. Received or receivable in cash from other sources (including rollovers) | 2021-12-31 | $451,769 |
Value of other receiveables (less allowance for doubtful accounts) at end of year | 2021-12-31 | $27 |
Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2021-12-31 | $63 |
Other income not declared elsewhere | 2021-12-31 | $773 |
Administrative expenses (other) incurred | 2021-12-31 | $21,624 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2021-12-31 | No |
Value of net income/loss | 2021-12-31 | $3,029,170 |
Value of net assets at end of year (total assets less liabilities) | 2021-12-31 | $10,767,910 |
Value of net assets at beginning of year (total assets less liabilities) | 2021-12-31 | $7,738,740 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2021-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2021-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2021-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2021-12-31 | $9,885,229 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2021-12-31 | $6,684,605 |
Interest on participant loans | 2021-12-31 | $5,511 |
Interest earned on other investments | 2021-12-31 | $16,901 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2021-12-31 | $1 |
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2021-12-31 | $1 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2021-12-31 | $1 |
Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2021-12-31 | $735,318 |
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2021-12-31 | $839,251 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2021-12-31 | $1,068,007 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2021-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2021-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2021-12-31 | No |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2021-12-31 | $579,371 |
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2021-12-31 | No |
Did the plan have assets held for investment | 2021-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2021-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2021-12-31 | No |
Opinion of an independent qualified public accountant for this plan | 2021-12-31 | Unqualified |
Accountancy firm name | 2021-12-31 | FORVIS, LLP |
Accountancy firm EIN | 2021-12-31 | 440160260 |
2020 : UNIVERSITY CLINICAL HEALTH 403B PLAN 2020 401k financial data |
---|
Total income from all sources (including contributions) | 2020-12-31 | $2,799,735 |
Total of all expenses incurred | 2020-12-31 | $532,776 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2020-12-31 | $520,900 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2020-12-31 | $1,857,378 |
Value of total assets at end of year | 2020-12-31 | $7,738,740 |
Value of total assets at beginning of year | 2020-12-31 | $5,471,781 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2020-12-31 | $11,876 |
Total interest from all sources | 2020-12-31 | $23,229 |
Total dividends received (eg from common stock, registered investment company shares) | 2020-12-31 | $103,503 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2020-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2020-12-31 | $103,503 |
Was this plan covered by a fidelity bond | 2020-12-31 | Yes |
Value of fidelity bond cover | 2020-12-31 | $500,000 |
If this is an individual account plan, was there a blackout period | 2020-12-31 | No |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2020-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2020-12-31 | No |
Contributions received from participants | 2020-12-31 | $1,689,147 |
Participant contributions at end of year | 2020-12-31 | $165,178 |
Participant contributions at beginning of year | 2020-12-31 | $66,274 |
Participant contributions at end of year | 2020-12-31 | $29,462 |
Participant contributions at beginning of year | 2020-12-31 | $0 |
Assets. Other investments not covered elsewhere at end of year | 2020-12-31 | $20,180 |
Income. Received or receivable in cash from other sources (including rollovers) | 2020-12-31 | $168,231 |
Value of other receiveables (less allowance for doubtful accounts) at end of year | 2020-12-31 | $63 |
Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2020-12-31 | $117 |
Other income not declared elsewhere | 2020-12-31 | $3,729 |
Administrative expenses (other) incurred | 2020-12-31 | $11,876 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2020-12-31 | No |
Value of net income/loss | 2020-12-31 | $2,266,959 |
Value of net assets at end of year (total assets less liabilities) | 2020-12-31 | $7,738,740 |
Value of net assets at beginning of year (total assets less liabilities) | 2020-12-31 | $5,471,781 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2020-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2020-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2020-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2020-12-31 | $6,684,605 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2020-12-31 | $4,715,273 |
Interest on participant loans | 2020-12-31 | $4,338 |
Interest earned on other investments | 2020-12-31 | $18,891 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2020-12-31 | $1 |
Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2020-12-31 | $839,251 |
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2020-12-31 | $690,117 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2020-12-31 | $811,896 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2020-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2020-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2020-12-31 | No |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2020-12-31 | $520,900 |
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2020-12-31 | No |
Did the plan have assets held for investment | 2020-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2020-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2020-12-31 | No |
Opinion of an independent qualified public accountant for this plan | 2020-12-31 | Disclaimer |
Accountancy firm name | 2020-12-31 | DIXON HUGHES GOODMAN LLP |
Accountancy firm EIN | 2020-12-31 | 560747981 |
2019 : UNIVERSITY CLINICAL HEALTH 403B PLAN 2019 401k financial data |
---|
Total income from all sources (including contributions) | 2019-12-31 | $3,242,708 |
Total of all expenses incurred | 2019-12-31 | $215,366 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2019-12-31 | $205,530 |
Value of total corrective distributions | 2019-12-31 | $554 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2019-12-31 | $2,517,635 |
Value of total assets at end of year | 2019-12-31 | $5,471,781 |
Value of total assets at beginning of year | 2019-12-31 | $2,444,439 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2019-12-31 | $9,282 |
Total interest from all sources | 2019-12-31 | $8,385 |
Total dividends received (eg from common stock, registered investment company shares) | 2019-12-31 | $82,351 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2019-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2019-12-31 | $82,351 |
Was this plan covered by a fidelity bond | 2019-12-31 | Yes |
Value of fidelity bond cover | 2019-12-31 | $500,000 |
If this is an individual account plan, was there a blackout period | 2019-12-31 | No |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2019-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2019-12-31 | No |
Contributions received from participants | 2019-12-31 | $1,576,269 |
Participant contributions at end of year | 2019-12-31 | $66,274 |
Participant contributions at beginning of year | 2019-12-31 | $5,377 |
Income. Received or receivable in cash from other sources (including rollovers) | 2019-12-31 | $941,366 |
Value of other receiveables (less allowance for doubtful accounts) at end of year | 2019-12-31 | $117 |
Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2019-12-31 | $2 |
Administrative expenses (other) incurred | 2019-12-31 | $9,282 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2019-12-31 | No |
Value of net income/loss | 2019-12-31 | $3,027,342 |
Value of net assets at end of year (total assets less liabilities) | 2019-12-31 | $5,471,781 |
Value of net assets at beginning of year (total assets less liabilities) | 2019-12-31 | $2,444,439 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2019-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2019-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2019-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2019-12-31 | $4,715,273 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2019-12-31 | $2,303,182 |
Interest on participant loans | 2019-12-31 | $449 |
Interest earned on other investments | 2019-12-31 | $7,936 |
Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2019-12-31 | $690,117 |
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2019-12-31 | $135,878 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2019-12-31 | $634,337 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2019-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2019-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2019-12-31 | No |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2019-12-31 | $205,530 |
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2019-12-31 | No |
Did the plan have assets held for investment | 2019-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2019-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2019-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2019-12-31 | Yes |
Opinion of an independent qualified public accountant for this plan | 2019-12-31 | Disclaimer |
Accountancy firm name | 2019-12-31 | WATKINS UIBERALL |
Accountancy firm EIN | 2019-12-31 | 621804252 |
2018 : UNIVERSITY CLINICAL HEALTH 403B PLAN 2018 401k financial data |
---|
Total income from all sources (including contributions) | 2018-12-31 | $1,743,369 |
Total of all expenses incurred | 2018-12-31 | $128,806 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2018-12-31 | $125,653 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2018-12-31 | $1,943,037 |
Value of total assets at end of year | 2018-12-31 | $2,444,439 |
Value of total assets at beginning of year | 2018-12-31 | $829,876 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2018-12-31 | $3,153 |
Total interest from all sources | 2018-12-31 | $1,178 |
Total dividends received (eg from common stock, registered investment company shares) | 2018-12-31 | $45,194 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2018-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2018-12-31 | $45,194 |
Was this plan covered by a fidelity bond | 2018-12-31 | Yes |
Value of fidelity bond cover | 2018-12-31 | $500,000 |
If this is an individual account plan, was there a blackout period | 2018-12-31 | No |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2018-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2018-12-31 | No |
Contributions received from participants | 2018-12-31 | $1,456,973 |
Participant contributions at end of year | 2018-12-31 | $5,377 |
Income. Received or receivable in cash from other sources (including rollovers) | 2018-12-31 | $486,064 |
Value of other receiveables (less allowance for doubtful accounts) at end of year | 2018-12-31 | $2 |
Administrative expenses (other) incurred | 2018-12-31 | $3,153 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2018-12-31 | No |
Value of net income/loss | 2018-12-31 | $1,614,563 |
Value of net assets at end of year (total assets less liabilities) | 2018-12-31 | $2,444,439 |
Value of net assets at beginning of year (total assets less liabilities) | 2018-12-31 | $829,876 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2018-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2018-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2018-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2018-12-31 | $2,303,182 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2018-12-31 | $814,237 |
Interest on participant loans | 2018-12-31 | $133 |
Interest earned on other investments | 2018-12-31 | $1,045 |
Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2018-12-31 | $135,878 |
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2018-12-31 | $15,639 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2018-12-31 | $-246,040 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2018-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2018-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2018-12-31 | No |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2018-12-31 | $125,653 |
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2018-12-31 | No |
Did the plan have assets held for investment | 2018-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2018-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2018-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2018-12-31 | Yes |
Opinion of an independent qualified public accountant for this plan | 2018-12-31 | Disclaimer |
Accountancy firm name | 2018-12-31 | WATKINS UIBERALL |
Accountancy firm EIN | 2018-12-31 | 621804252 |
2017 : UNIVERSITY CLINICAL HEALTH 403B PLAN 2017 401k financial data |
---|
Total income from all sources (including contributions) | 2017-12-31 | $837,040 |
Total of all expenses incurred | 2017-12-31 | $7,164 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2017-12-31 | $6,592 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2017-12-31 | $799,517 |
Value of total assets at end of year | 2017-12-31 | $829,876 |
Value of total assets at beginning of year | 2017-12-31 | $0 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2017-12-31 | $572 |
Total interest from all sources | 2017-12-31 | $70 |
Total dividends received (eg from common stock, registered investment company shares) | 2017-12-31 | $9,674 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2017-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2017-12-31 | $9,674 |
Was this plan covered by a fidelity bond | 2017-12-31 | Yes |
Value of fidelity bond cover | 2017-12-31 | $500,000 |
If this is an individual account plan, was there a blackout period | 2017-12-31 | No |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2017-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2017-12-31 | No |
Contributions received from participants | 2017-12-31 | $793,580 |
Income. Received or receivable in cash from other sources (including rollovers) | 2017-12-31 | $5,937 |
Administrative expenses (other) incurred | 2017-12-31 | $572 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2017-12-31 | No |
Value of net income/loss | 2017-12-31 | $829,876 |
Value of net assets at end of year (total assets less liabilities) | 2017-12-31 | $829,876 |
Value of net assets at beginning of year (total assets less liabilities) | 2017-12-31 | $0 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2017-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2017-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2017-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2017-12-31 | $814,237 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2017-12-31 | $0 |
Interest earned on other investments | 2017-12-31 | $70 |
Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2017-12-31 | $15,639 |
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2017-12-31 | $0 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2017-12-31 | $27,779 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2017-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2017-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2017-12-31 | No |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2017-12-31 | $6,592 |
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2017-12-31 | No |
Did the plan have assets held for investment | 2017-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2017-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2017-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2017-12-31 | Yes |
Opinion of an independent qualified public accountant for this plan | 2017-12-31 | Disclaimer |
Accountancy firm name | 2017-12-31 | WATKINS UIBERALL |
Accountancy firm EIN | 2017-12-31 | 621804252 |